(19)
(11) EP 1 624 866 A2

(12)

(88) Date of publication A3:
17.03.2005

(43) Date of publication:
15.02.2006 Bulletin 2006/07

(21) Application number: 04752462.4

(22) Date of filing: 17.05.2004
(51) International Patent Classification (IPC): 
A61K 31/405(1985.01)
A61P 11/06(2000.01)
 A61P 11/00(2000.01)
A61P 11/08(2000.01)
(86) International application number:
PCT/US2004/015449
(87) International publication number:
WO 2004/103364 (02.12.2004 Gazette 2004/49)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 16.05.2003 US 471283 P
19.05.2003 US 471896 P
05.11.2003 US 517937 P

(71) Applicant: Arriva Pharmaceuticals, Inc.
Alameda, CA 94501 (US)

(72) Inventors:
  • BARR, Philip, J.
    Oakland, CA 94619 (US)
  • PEMBERTON, Philip, A.
    San Mateo, CA 94402 (US)

(74) Representative: Roques, Sarah Elizabeth et al
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) TREATMENT OF RESPIRATORY DISEASE BY INHALATION OF SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS